F3Logic’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-6,089
Closed -$202K 236
2021
Q1
$202K Buy
+6,089
New +$209K 0.03% 230
2020
Q3
Sell
-9,767
Closed -$217K 446
2020
Q2
$217K Buy
+9,767
New +$202K 0.04% 163
2019
Q3
Sell
-10,547
Closed -$221K 147
2019
Q2
$221K Buy
+10,547
New +$218K 0.04% 188

Other funds holding BOUT

F3Logic's BOUT Position: Q2 2021 in Review

F3Logic sold out of CapForce IBD Breakout Opportunities ETF (BOUT) in Q2 2021, closing a stake of 6,089 shares — an estimated $202K sold.

F3Logic first reported a position in BOUT in Q2 2019 and held it in 3 quarters. The position peaked at $221K in Q2 2019. 11 funds tracked by Wall St. Rank hold BOUT as of Q2 2021.

  • F3Logic reported no remaining CapForce IBD Breakout Opportunities ETF position as of Q2 2021 after selling out during the quarter.
  • F3Logic sold 6,089 CapForce IBD Breakout Opportunities ETF shares in Q2 2021, an estimated $202K.
  • F3Logic first reported a position in CapForce IBD Breakout Opportunities ETF in Q2 2019 and held it in 3 quarters.
  • F3Logic's CapForce IBD Breakout Opportunities ETF position peaked at $221K in Q2 2019.
  • 11 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q2 2021.

Based on F3Logic's 13F filing for Q2 2021, filed 10 Aug 2021.